课题基金 / 基金详情

The comparison of QOL and cost between hemodialysis and peritoneal dialysis

The comparison of QOL and cost between hemodialysis and peritoneal dialysis
血液透析与腹膜透析的生活质量和费用比较
批准号:
09470515
负责人:
KOINUMA Nobuo
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

KOINUMA Nobuo的其他基金

相似基金

相关文献

中文摘要
翻译
【目的】肾透析一直面临着复杂并发症、长期护理给家庭带来负担、治疗费用高等严重问题。血液透析(HD)与腹膜透析(PD)的生活质量和成本比较,在各国存在较大差异,对提高肾透析的效率和质量至关重要。[方法]收集4个肾透析中心158例终末期肾病患者的资料;140例HD患者和18例PD患者。采用含线性模拟量表的问卷,在2年的每个透析日对患者进行自我评估,并从家属和医务人员的角度评估患者的生活质量。并对每个病例的医疗费用数据进行了汇总。[结果]50例HD患者随访2年,自我评价的生活质量评分与护士评价的生活质量评分呈正相关(p<0.01)。这意味着护理人员可以准确地掌握病人的健康状况。透析前自我评价的生活质量评分与医疗费用呈负相关(p<0.01)。当需要对意外并发症进行针对性的药物治疗时,自我评价的生活质量评分往往较低。HD患者倦怠的方差大于PD患者(p<0.05)。PD患者的生活质量有提高的趋势,但由于PD病例数量与HD病例相比不足,无法进行更多的统计分析。
英文摘要
[Purpose] Renal dialysis has been faced with such serious problems as compound complications, burden of the family cause by long-term care, and the high cost of the therapy. The comparison of QOL and cost between hemodialysis (HD) and peritoneal dialysis (PD) in which there is comparatively a great difference by the country seems to be essential to improve efficiency and quality of the renal dialysis.[Methods] The data were collected in four renal dialysis centers for 158 patients with end stage renal disease ; 140 patients undergoing HD and 18 PD patients. QOL of the patient was assessed by himself and from the viewpoints of family and the medical staff in every dialysis day for 2 years using questionnaires containing linear analogue scale. The data of medical cost in each case were also accumulated.[Results] A positive correlation was seen between the QOL scores by self-estimation and those estimated by nurses in 50 patients with HD followed for two years (p<0.01). This means that the attendant nurses accurately grasp the patient's health status. There was a negative correlation between QOL scores by self-estimation before the dialysis and medical cost (p<0.01). When the specific medical treatments for unexpected complications are needed, QOL scores by self-estimation tend to become low. The variance of languor in HD patients is bigger than that in PD patients (p<0.05). QOL is in the trend that becomes higher with PD patients, although the more statistical analysis was impossible because number of PD cases is not sufficient in comparison with HD cases.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
濃沼信夫: "費用についてのインフォームド・コンセント、インフォームド・コンセントガイダンス(がん診療編、盛岡恭彦編)"先端医学社. 16 (1999)
Nobuo Nonuma:“关于费用的知情同意,知情同意指导(癌症治疗,盛冈康彦编辑)”仙台医学社 16(1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
濃沼信夫: "癌検診の現状と経済性." Medical Practice(臨時増刊号「実地医家のための癌臨床ガイド」). 47-56 (1997)
Nobuo Nonuma:“癌症筛查的现状和经济学”(特刊“实用医师癌症临床指南”)47-56(1997 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
濃沼信夫: "在院期間による病床区分のインパクト" ばんぶう. 212. 54-59 (1999)
Nobuo Nonuma:“基于住院时间的床位分类的影响”Banbuu 212. 54-59 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
濃沼信夫: "クリニカル・インディケーターによる評価." Medical QOL. 30. 16-18 (1997)
Nobuo Onuma:“使用临床指标进行评估。”30. 16-18 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 20 条
    Economic benefit of Helicobacter pylori screening and eradication treatment for the prevention of gastric cancer
    • 批准号:
      22659098
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.1万
    • 财政年份:
      2010
    • 负责人:
      KOINUMA Nobuo
    • 依托单位:
    The significance of the PSA screening for prostate cancer from social and economic viewpoints
    • 批准号:
      21390157
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2009
    • 负责人:
      KOINUMA Nobuo
    • 依托单位:
    Health economics on patient safety aiming at the point of human resources
    • 批准号:
      18390157
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.4万
    • 财政年份:
      2006
    • 负责人:
      KOINUMA Nobuo
    • 依托单位:
    A study of economic effect of non-smoking using a system model
    • 批准号:
      15390165
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.65万
    • 财政年份:
      2003
    • 负责人:
      KOINUMA Nobuo
    • 依托单位:
    海外基金